Skip to main navigation Skip to search Skip to main content

Diminished Prognostic Value of Interim PET in Hodgkin Lymphoma Treated with Brentuximab Vedotin Plus AVD: A Retrospective Analysis

  • Kareem Latif
  • , Isaiah Courtad
  • , Avery Stuart
  • , Faisal Ansari
  • , Ravand Samaeekia
  • , Mojtaba Akhtari

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Article number53
JournalHematology Reports
Volume18
Issue number4
DOIs
StatePublished - Aug 2026

ASJC Scopus Subject Areas

  • Hematology

Keywords

  • Hodgkin lymphoma
  • brentuximab vedotin
  • positron emission tomography
  • response-adapted therapy

Cite this